10x Genomics, Inc. TXG Ratios & Valuation
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Profitability | |||||
| Gross margin | 69.1%+1.2pp | 67.9%+1.7pp | 66.2%-10.5pp | 76.7%-8.2pp | |
| Operating margin | -9.5%+22.4pp | -31.9%+11.0pp | -42.9%-10.4pp | -32.5%-21.9pp | |
| Net margin | -6.8%+23.1pp | -29.9%+11.3pp | -41.2%-9.1pp | -32.1%-20.3pp | |
| EBITDA margin | -3.9%+22.1pp | -26%+11.2pp | -37.1%-9.5pp | -27.6%-21.3pp | |
| Free cash flow margin | 20.2%— | —— | —— | -32%-7.0pp | |
| Returns | |||||
| Return on equity | -5.8%+19.4pp | -25.2%+7.8pp | -33%-12.5pp | -20.5%-13.0pp | |
| Return on assets | -4.4%+14.9pp | -19.4%+6.2pp | -25.6%-9.4pp | -16.2%-10.2pp | |
| Return on invested capital | -14.3%+27.8pp | -42%+4.1pp | -46.1%-11.7pp | -34.4%-9.3pp | |
| Efficiency | |||||
| Asset turnover | 0.7×0.0× | 0.6×0.0× | 0.6×+0.1× | 0.5×0.0× | |
| Inventory turnover | 2.9×+0.3× | 2.5×-0.2× | 2.7×+1.0× | 1.7×+0.1× | |
| Liquidity | |||||
| Current ratio | 4.5×-0.5× | 5×+0.3× | 4.7×-0.2× | 4.8×-1.9× | |
| Quick ratio | 4.1×-0.2× | 4.3×+0.2× | 4.1×-0.1× | 4.2×-2.0× | |
| Cash ratio | 3.1×+0.2× | 2.9×+0.1× | 2.8×+1.1× | 1.7×-3.7× | |
| Leverage | |||||
| Debt-to-equity | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | |
| Debt-to-assets | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | |
| Per Share | |||||
| Book value per share | $6.38+8.3% | $5.90-6.8% | $6.32-10.6% | $7.08-4.5% | |
| Valuation | |||||
| Market capitalization | $2.06B+18.7% | $1.74B-73.8% | $6.63B+59.1% | $4.17B-74.9% | |
| Enterprise value | $1.67B+13.4% | $1.48B-76.8% | $6.37B+57.7% | $4.04B-75.0% | |
| Price / sales | 3.2×+0.4× | 2.8×-7.9× | 10.7×+2.6× | 8.1×-25.8× | |
| Price / book | 2.6×+0.1× | 2.4×-6.5× | 9×+3.8× | 5.2×-15.2× | |
| EV / sales | 2.6×+0.2× | 2.4×-7.9× | 10.3×+2.5× | 7.8×-25.1× | |
| Free cash flow yield | 6.3%— | —— | —— | -4%-3.2pp | |
| Earnings yield | -2.1%+8.4pp | -10.5%-6.7pp | -3.8%+0.1pp | -4%-3.6pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are 10x Genomics, Inc.'s profit margins?
- 10x Genomics, Inc. (TXG) runs a 69.6% gross margin and a -6.1% operating margin, with a -3.5% net margin.
- Where do 10x Genomics, Inc.'s ratios come from?
- Every ratio is computed from 10x Genomics, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.